Core Laboratories (CLB) Long-Term Investments (2022 - 2025)

Core Laboratories has reported Long-Term Investments for 4 years, with the latest figure at $4.4 million in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Investments fell 12.87% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $4.4 million (down 12.87% YoY), and the FY2025 full-year result was $4.4 million, down 12.87% from the prior year.
• Long-Term Investments for Q4 2025 stood at $4.4 million, down from $5.1 million in the prior quarter.
• The five-year high for Long-Term Investments was $5.1 million in Q4 2024, with the low at $4.4 million in Q4 2025.
• Historically, Long-Term Investments has averaged $4.7 million across 4 years, with a median of $4.6 million in 2022.
• Annual changes were most pronounced in 2023 — Long-Term Investments rose 8.85% — and 2025, when it retreated 12.87%.
• Core Laboratories' Long-Term Investments stood at $4.4 million in 2022, then climbed by 8.85% to $4.8 million in 2023, then advanced by 4.87% to $5.1 million in 2024, then decreased by 12.87% to $4.4 million in 2025.
• The last three Long-Term Investments figures came in at $4.4 million (Q4 2025), $5.1 million (Q4 2024), and $4.8 million (Q4 2023), per Business Quant data.